AB186. The efficacy and safety of sorafenib in Chinese patients with metastatic renal cell carcinoma and prognostic factors related to its efficacy

OBJECTIVE: Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinoma (mRCC) by several guidelines. The objective of this study is to evaluate the efficacy of Sorafenib treatments on Chinese patients with mRCC. METHODS: The characteristics and outcomes of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoteng, Guo, Gang, Li, Xuesong, Zhang, Cuijian, Huang, Lihua, Fang, Dong, Song, Yi, Zhang, Xu, Zhou, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2015
Materias:
Accepted Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708839/
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708839/
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s186

Ejemplares similares